UNIXELL BIOTECHNOLOGY
Yuesai Biotechnology is a cell therapy drug developer that uses human pluripotent stem cell technology. Yuesai Biotechnology develops stem cell therapy for neurodegenerative diseases, rare diseases, and tumors using its proprietary intellectual property rights of human pluripotent stem cell preparation, cultivation, differentiation, and gene editing technology platform.
UNIXELL BIOTECHNOLOGY
Industry:
Biotechnology
Founded:
2021-06-01
Address:
Pudong, Shandong, China
Country:
China
Website Url:
http://www.unixell.com
Total Employee:
11+
Status:
Active
Total Funding:
300 M CNY
Similar Organizations
Avant Meats
Avant Meats is a technology company with patent-pending solutions to produce animal meat and protein without the animal
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Code Biotherapeutics
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.
EnviroKure, Incorporated
Disruptive ag biotechnology to enhance plant growth and productivity, builds healthy soil and can reduce the need for chemical fertilizers.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Investors List
CASVC
CASVC investment in Series A - UniXell Biotechnology
Tasly Capital
Tasly Capital investment in Series A - UniXell Biotechnology
Pudong Chuangtou
Pudong Chuangtou investment in Series A - UniXell Biotechnology
KUNLUN
KUNLUN investment in Seed Round - UniXell Biotechnology
TF Capital
TF Capital investment in Seed Round - UniXell Biotechnology
Fosun Pharma
Fosun Pharma investment in Seed Round - UniXell Biotechnology
Ruihua Venture Capital
Ruihua Venture Capital investment in Seed Round - UniXell Biotechnology
CDH Investments
CDH Investments investment in Seed Round - UniXell Biotechnology
Hillhouse Investment
Hillhouse Investment investment in Seed Round - UniXell Biotechnology
Sherpa Healthcare Partners
Sherpa Healthcare Partners investment in Seed Round - UniXell Biotechnology
Official Site Inspections
http://www.unixell.com
- Host name: 36.138.223.14
- IP address: 36.138.223.14
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "UniXell Biotechnology"
UniXell - Crunchbase Company Profile & Funding
Organization. UniXell . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. UniXell develops cell therapies for the treatment …See details»
上海跃赛生物科技有限公司 - unixell.com
UniXell is an innovative biotechnology company specialized in developing hPSC based cell therapy products. Since its founding in 2021, Unixell has developed multiple key technology platforms, including Reprogramming technology, …See details»
UniXell Biotechnology 2025 Company Profile: Valuation, Funding ...
UniXell Biotechnology General Information Description. Developer of cellular therapy based on human pluripotent stem cells. The company focuses on unmet medical needs, including …See details»
UniXell Biotechnology - Products, Competitors, Financials, …
UniXell Biotechnology provides pharmaceutical solutions with a focus on developing a new generation of cell therapy drugs based on human pluripotent stem cells. It offers a …See details»
Shanghai Unixell Biotechnology Co. Ltd. - BioCentury Company …
Shanghai Unixell Biotechnology Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
What is UniXell Biotechnology? Company Culture, Mission, Values
See what employees say it's like to work at UniXell Biotechnology. Salaries, reviews, and more - all posted by employees working at UniXell Biotechnology.See details»
上海跃赛生物科技有限公司
Oct 14, 2024 跃赛生物是一家专注于开发新一代基于人多能干细胞的细胞治疗药物的创新型制药公司。 自2021年创立以来，团队开发了重编程技术平台、干细胞分化平台、sisbar谱系示踪技 …See details»
UniXell - Crunchbase
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.See details»
上海跃赛生物科技有限公司 - unixell.com
UniXell Biotechnology, a leading company in the field of human PSC derived cell therapy for neurological diseases, was founded in 2021 with R&D center and GMP facility covering a total …See details»
UniXell Biotechnology - Crunchbase Company Profile & Funding
Organization. UniXell Biotechnology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. UniXell Biotechnology is a new …See details»
UniXell - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Aug 1, 2021: Angel Round - …See details»
UniXell - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. UniXell . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. Edit Patents and …See details»
UniXell DA-001 - Drug Targets, Indications, Patents - Synapse
UniXell DA-001, Initially developed by Shanghai Yusai Biotechnology Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System …See details»
上海跃赛生物科技有限公司 - unixell.com
上海跃赛生物科技有限公司，全球人多能干细胞来源神经系统疾病细胞疗法的领军企业，成立于2021年，在上海市自由贸易试验区自贸壹号生命科技产业园二期建有总面积约4000平米的研 …See details»
UniXell Biotechnology - Funding, Financials, Valuation & Investors
UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs. New. Resources. ... How much …See details»
UX-DA001 in Parkinson Disease, Idiopathic - ICH GCP
Dec 30, 2024 March 26, 2025 updated by: Shanghai UniXell Biotechnology Co., Ltd. An Exploratory Clinical Study to Evaluate UX-DA001 Injection (Human Midbrain Dopaminergic …See details»
Working at UniXell Biotechnology - Glassdoor
Glassdoor gives you an inside look at what it's like to work at UniXell Biotechnology, including salaries, reviews, office photos, and more. This is the UniXell Biotechnology company profile. …See details»
上海跃赛生物科技有限公司 - unixell.com
Mar 14, 2022 (UniXell), a leader in the field of pluripotent stem cell drug development, announced the completion of tens of millions of yuan angel round financing. This round of …See details»
Unixell-Bioinformatics - GitHub
GitHub is where Unixell-Bioinformatics builds software. GitHub is where Unixell-Bioinformatics builds software. Skip to content. Navigation Menu Toggle navigation. Sign in UnixellTest. …See details»
UniXell - Updates, News, Events, Signals & Triggers - Crunchbase
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.See details»